Elevance Health (ELV) Change in Cash (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Cash data on file, last reported at $166.0 million in Q1 2026.

• Change in Cash for Q1 2026 came in at $166.0 million, up 121.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 60.97% YoY), and the FY2025 annual result was $1.2 billion, down 34.19% from the prior year.
• Change in Cash eased to $166.0 million in Q1 2026 per ELV's latest filing, from $778.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $2.8 billion in Q1 2023 and troughed at -$4.4 billion in Q4 2023.
• A 5-year average of $284.9 million and a median of $295.0 million in 2022 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2023: Change in Cash soared 941.38% in 2022, then sank 195.82% in 2023.
• A 5-year view of Change in Cash shows it stood at -$1.5 billion in 2022, then slumped by 195.82% to -$4.4 billion in 2023, then jumped by 110.65% to $468.0 million in 2024, then surged by 66.24% to $778.0 million in 2025, then slumped by 78.66% to $166.0 million in 2026.
• Business Quant data shows ELV's Change in Cash at $166.0 million in Q1 2026, $778.0 million in Q4 2025, and $153.0 million in Q3 2025.